Humira Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira ®) in Healthy Adult Japanese Participants
Condition:   Healthy Volunteers Interventions:   Drug: ABP 501;   Drug: Adalimumab Sponsor:   Amgen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials

PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
Condition:   Crohn Disease Interventions:   Biological: TNFa Antagonist - Infliximab;   Biological: TNFa Antagonist - Adalimumab;   Biological: Anti-IL12/23 or anti-IL23 - Ustekinumab;   Biological: Anti-IL12/23 or anti-IL23 - Risankizumab;   Biological: Anti-integrin - Vedolizumab IV;   Biological: Anti-integrin - Ved olizumab IV and SC Sponsors:   University of Calgary;   Alimentiv Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials